增视汤离子导入联合托吡卡胺滴眼液治疗青少年假性近视临床研究  

Clinical Study on Combination Use of Iontophoresis of Zengshi Decoction and Tropicamide Eye Drops for Pseudomyopia in Youngsters

作　　者：宋春艳 方健 张晓丹 杨丽娜 SONG Chunyan;FANG Jian;ZHANG Xiaodan;YANG Li'na(Department of Ophthalmology,Xinchang Hospital Affiliated to Wenzhou Medical University,Xinchang Zhejiang 325000,China)

机构地区：[1]温州医科大学附属新昌医院眼科,浙江新昌325000

出　　处：《新中医》2024年第22期105-108,共4页New Chinese Medicine

摘　　要：目的:观察增视汤离子导入联合托吡卡胺滴眼液治疗青少年假性近视的临床疗效。方法:选取240例青少年假性近视患者,采用随机数字表法分为对照组和治疗组各120例。对照组给予托吡卡胺滴眼液治疗,治疗组在对照组的基础上加用增视汤离子导入治疗,2组均治疗1个月,比较2组临床疗效、中医证候评分、视力指标(晶状体厚度、前房深度、裸眼视力)、最佳矫正视力、散光度、屈光度。结果:治疗组总有效率为95.00%,对照组为75.00%,2组比较,差异有统计学意义(P<0.05)。治疗后,2组视物昏花、头晕头痛、心烦、腰膝酸软等中医证候评分均较治疗前降低(P<0.05),且治疗组各项评分均低于对照组(P<0.05)。治疗后,2组裸眼视力均较治疗前提高(P<0.05),且治疗组高于对照组(P<0.05);2组晶状体厚度、前房深度均较治疗前减小(P<0.05),且治疗组2项视力指标水平小于对照组(P<0.05)。治疗后,2组散瞳后屈光度均较治疗前升高(P<0.05),且治疗组散瞳后屈光度高于对照组(P<0.05);2组散光度、最佳矫正视力治疗前后及治疗后组间比较,差异均无统计学意义(P>0.05)。结论:增视汤离子导入联合托吡卡胺滴眼液能够改善中医证候、相关视力指标水平及散瞳后屈光度,提高临床疗效。Objective:To observe the clinical effect of the combination use of iontophoresis of Zengshi Decoction and Tropicamide Eye Drops on pseudomyopia in youngsters.Methods:A total of 240 youngsters with pseudomyopia were selected and divided into the control group and the treatment group according to the random number table method,with 120 cases in each group.The control group was treated with Tropicamide Eye Drops,and the treatment group was additionally treated with iontophoresis of Zengshi Decoction based on the treatment of the control group.After one month of treatment,the clinical effects,traditional Chinese medicine(TCM)syndrome scores,visual acuity indexes(lens thickness,anterior chamber depth and uncorrected visual acuity),best corrected visual acuity,astigmatism,and diopter were compared between the two groups.Results:The total effective rate was 95.00%in the treatment group and 75.00%in the control group,the difference being significant(P<0.05).After treatment,the TCM syndrome scores of blurred vision,dizziness and headache,upset,soreness and weakness of waist and knees in the two groups were decreased when compared with those before treatment(P<0.05),and the above scores in the treatment group were lower than those in the control group(P<0.05).After treatment,the uncorrected visual acuity in the two groups was increased when compared with that before treatment(P<0.05),and the increase rate in the treatment group was higher than that in the control group(P<0.05);the lens thickness and anterior chamber depth in the two groups were decreased than those before treatment(P<0.05),and the two visual acuity indexes in the treatment group was less than that in the control group(P<0.05).After treatment,the diopter after mydriasis in the two groups was elevated when compared with that before treatment(P<0.05),and the diopter after mydriasis in the treatment group was higher than that in the control group(P<0.05);there was no significant difference being found in the comparisons of astigmatism and best corrected visual

关 键 词：假性近视 青少年 增视汤 托吡卡胺滴眼液 离子导入 裸眼视力 

分 类 号：R778.11[医药卫生—眼科]